Literature DB >> 20652966

Reproducibility of tricuspid regurgitant jet velocity measurements in children and young adults with sickle cell disease undergoing screening for pulmonary hypertension.

Robert I Liem1, Luciana T Young, Amy S Lay, Stephanie A Pelligra, Richard J Labotka, Alexis A Thompson.   

Abstract

The reproducibility of tricuspid regurgitant jet velocity (TRJV) measurements by Doppler echocardiography has not been subjected to systematic evaluation among individuals with sickle cell disease (SCD) undergoing screening for pulmonary hypertension. We examined sources of disagreement associated with peak TRJV in children and young adults with SCD. Peak TRJV was independently measured and interpreted a week apart by separate sonographers and readers, respectively, in 30 subjects (mean age, 15.8 ± 3.3 years) who provided 120 observations. We assessed intra-/inter-reader, intra-/inter-sonographer, sonographer-reader, and within subject agreement using Intraclass Correlation Coefficient (ICC) and Cohen's kappa (κ). Agreement was examined graphically using Bland-Altman plots. Although sonographers could estimate and measure peak TRJV in all subjects, readers designated tricuspid regurgitation nonquantifiable in 10-17% of their final interpretations. Intra-reader agreement was highest (ICC = 0.93 [95% CI 0.86, 0.97], P = 0.0001) and within subject agreement lowest (ICC = 0.36 [95% CI 0.02, 0.64], P = 0.021) for single TRJV measurements. Similarly, intra-reader agreement was highest (κ = 0.74 [95% CI 0.53, 0.95], P = 0.0001) and within subject lowest (κ = 0.14 [95% CI -0.17, 0.46], P = 0.38) when sonographers and readers categorized TRJV measurements. On Bland-Altman plots, absolute differences in observations increased with higher mean TRJV readings for intra-/inter-reader agreement. Peak TRJV measurements in individual children and young adults with SCD are affected by several sources of disagreement, underscoring the need for methodological improvements that ensure reproducibility of this screening modality for making clinical decisions in this population.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20652966     DOI: 10.1002/ajh.21793

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  4 in total

1.  TRV: a physiological biomarker in sickle cell disease.

Authors:  Gregory J Kato
Journal:  Pediatr Blood Cancer       Date:  2011-12-16       Impact factor: 3.167

2.  Diastolic dysfunction is associated with exercise impairment in patients with sickle cell anemia.

Authors:  Tarek Alsaied; Omar Niss; Adam W Powell; Robert J Fleck; James F Cnota; Clifford Chin; Punam Malik; Charles T Quinn; Michael D Taylor
Journal:  Pediatr Blood Cancer       Date:  2018-05-21       Impact factor: 3.167

3.  Echocardiographic Screening of Cardiovascular Status in Pediatric Sickle Cell Disease.

Authors:  Kiona Y Allen; Shannon Jones; Tannoa Jackson; Grace DeCost; Paul Stephens; Brian D Hanna; Meryl S Cohen; Kim Smith-Whitley; Laura Mercer-Rosa; Shobha S Natarajan
Journal:  Pediatr Cardiol       Date:  2019-09-21       Impact factor: 1.655

4.  Novice Physician Ultrasound Evaluation of Pediatric Tricuspid Regurgitant Jet Velocity.

Authors:  Zachary W Binder; Sharon E O'Brien; Tehnaz P Boyle; Howard J Cabral; Sepehr Sekhavat; Joseph R Pare
Journal:  West J Emerg Med       Date:  2020-06-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.